-+ 0.00%
-+ 0.00%
-+ 0.00%

INTERPACE DIAGNOSTICS® ANNOUNCES UNDEFINED EXTENSION OF MEDICARE COVERAGE FOR PANCRAGEN®, A MOLECULAR DIAGNOSTIC TEST THAT ASSESSES CANCER RISK OF PANCREATIC CYSTS

Reuters·07/29/2024 12:25:00

Please log in to view news